Skip to main content
. 2021 Nov 25;22(23):12736. doi: 10.3390/ijms222312736

Table A1.

List of Huntington’s disease models used in the reviewed studies.

Model Description Reference
CAG140 KI knock-in murine model expressing full-length Hdh gene with exon1 from human HTT with 140 CAG repeats [79]
HD-hiPSCs human-induced pluripotent stem cells derived from HD patients differentiated towards medium spiny neurons [32]
Htt-72Q murine primary cortical neuron model expressing HTT exon1 with 72 CAG repeats [8]
OVT73 transgenic sheep model expressing full-length human HTT cDNA with 73 CAG/CAA repeats under the control of the human promoter [80]
R6/1 murine model transgenic for the 5′ end of the HTT gene carrying 116 CAG repeats [81]
R6/2 murine model transgenic for the 5′ end of the HTT gene carrying 144 CAG repeats [81]
N171-82Q Transgenic murine model expressing N-terminal truncated human HTT cDNA with 82 CAG repeats under the influence of mouse prion protein promoter [82]
STHdhQ111 cell culture model derived from knock-in mouse embryos expressing full-length Hdh 1 with 111 CAG repeats [83]
YAC128 yeast artificial chromosome transgenic murine model expressing full-length HTT transgene with 128 CAG repeats [84]
zQ175 knock-in murine model expressing full-length Hdh gene with exon1 from human HTT with 188 CAG repeats, derived from CAG140 KI [85]

1 Murine homolog of human HTT.